Patent News for Wednesday 5th March 2025

1. ProAmpac enhances intellectual property portfolio with multiple US patents

... patents for its ProActive Sustainability product line ... The patents bolster the company's commitment to sustainable packaging innovation.

2. Panel swats down challenge to Apple's PTAB standing on forfeiture grounds | MLex

Gesture Technology Partners LLC forfeited the right to question Apple's standing, as a member of Unified Patents, to maintain inter partes review ...

3. Photonics IP Update: February 2025 | Laser Focus World

The patents describe a system for self-adaptive, scheduled LED lighting control. Samsung Electronics America, Inc. f/k/a Samsung Telecommunications ...

4. Bolstering Sustainable Packaging Leadership, ProAmpac Expands Intellectual Property Portfolio

ProAmpac, a global leader in flexible packaging and material science, is proud to announce the issuance of multiple U.S. patents for its ProActive ...

5. EU draft adequacy decision looks to ease data flows with European patents agency | MLex

EU draft adequacy decision looks to ease data flows with European patents agency. (March 5, 2025, 12:53 PM GMT) -- MLex Summary: Innovative ...

6. PathMaker Neurosystems Announces Issuance of Three Patents Protecting the Use of ...

These issued patents cover systems and methods for treating ALS and related diseases using a fundamentally novel approach that is delivered non- ...

7. US Court seeks assistance from Zurich authorities for testimony in OANDA patent ...

... Patents directed to trading currencies over a computer network. GAIN seeks evidence and testimony from a listed inventor on the patents, Dr.

8. PathMaker Neurosystems Announces Issuance of Three Patents - GlobeNewswire

PathMaker Neurosystems Announces Issuance of Three Patents Protecting the Use of Company's Proprietary Neuromodulation Technology in ALS...

9. The Muted Response Of Pharmaceutical Companies To The Establishment Of The Unitary ...

... Patents1 and European patents. The Agreement on a Unified Patent Court (UPCA) entered into force on 1st June 2023 with the intention of obviating ...

10. Allurion Announces Notification Of Issuance Of New U.S. Patents On Next-Generation ...

Allurion Technologies Inc: * ALLURION ANNOUNCES NOTIFICATION OF ISSUANCE OF NEW U.S. PATENTS ON NEXT-GENERATION WEIGHT LOSS DEVICE FOR THE ...

11. Interest to act for a declaratory of non-infringement in patent interim proceedings - Lexology

... patents. The applicants brought an action before the Court of Rome, enterprise chamber, seeking an interim declaration of non-infringement of the ...

12. Moderna and Freshfields triumph in Düsseldorf against BioNTech and Pfizer - JUVE Patent

Moderna accuses Pfizer and BioNTech of infringing both patents with their mRNA vaccine Comirnaty. Early on Moderna emphasised that it is not seeking ...

13. University of Arizona describes new PL-pro inhibitors for SARS-CoV-2 | BioWorld

To read more on related topics, click on one of the words below. BioWorld Science Infection Coronavirus Patents. KEYWORDS coronavirus COVID-19 PL-pro ...

14. Merck's Injectable Keytruda Plans Create Legal Dispute With Halozyme: WSJ - BioSpace

... patents, and that Merck needs to sign a licensing agreement. These petitions suggest the company is “tipping their hand that the Halozyme patents ...

15. Houston shines among top 10 tech metros in the South, study says

However, Houston leads the nation with the highest number of patents granted between 2020 and 2024. "The second-largest metro by population in the ...

16. New version of Merck's Keytruda faces possible patent battle, WSJ reports | Reuters

... patents on its original intravenous version expire later in the decade. ... "We strongly believe that any Halozyme patents that attempt to cover ...

17. New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race

PatentVest report uncovers China's dominance in AI data center patents while the market is projected to grow sixfold to $431.43B by 2030, ...

18. Patented: Amida Technology Solutions' Hardware Trojan Security System and ... - Dallas Innovates

Explore patents granted for the week of January 28, 2025, including ATT's intelligent security through precise mobile device location sensing and ...

19. Merck's Keytruda subject of brewing patent dispute with Halozyme, WSJ says

... patents for Halozyme's Mdase, arguing the patents were overly broad. Meanwhile, Halozyme believes the new Keytruda infringes on its patents and ...

20. Federal Circuit Affirms Partial Win for Patent Owner Against Apple - IPWatchdog.com

... Patents case. It did not, however, decide the question whether Apple actually was a real party in interest or privy of Unified Patents. Turning to ...

21. Crafting the perfect pitch: insights into business-to-investor marketing - EurekAlert!

Intellectual Capital: Patents and intellectual property. Costless Signals: Verbal cues that influence investor perception, such as: Passion ...

22. Strategic considerations as Korea prepares for new patent term extension system

Whether the patents are primary or secondary patents. For example, let us assume that there are four patents involved in a drug product X for ...

23. Fico awarded more patents - Finextra Research

Global analytics software leader FICO was awarded new patents by the U.S. Patent and Trademark Office, encompassing technologies in fraud, ...

24. Zen Technologies Awarded Third Patent for T-90 Tank Simulator - Machine Maker

Prior patents included those for the Basic Gunnery Simulator (BGS) and Crew Gunnery Simulator (CGS), along with patents for variants of the T-72 and ...

25. Amgen Challenges Opdivo® / Yervoy® Combination Treatment Patents in Three IPRs

On February 28, 2025, Amgen filed three IPRs against Bristol-Myers Squibb's patents covering methods of treatment using a combination of Opdivo®.

26. Case: Patents/Jurisdiction (Fed. Cir.) - Bloomberg Law News

Case: Patents/Jurisdiction (Fed. Cir.) The Federal Circuit dismissed AlexSam Inc.'s appeal of a decision of a federal district court granting ...

27. Case: Patents/Damages (Fed. Cir.) - Bloomberg Law News

Case: Patents/Damages (Fed. Cir.) The Federal Circuit affirmed the decision of the district of Nevada denying Halo Electronics Inc.'s motion for ...

28. Promega Files Patent Infringement Lawsuit Against Aobious to Protect Novel Luciferase Substrates

Promega also holds patents related to the structure of furimazine in 28 additional countries. Learn more about NanoLuc® luciferase and technologies ...

29. Patent clash looms over Merck & Co.'s subcutaneous Keytruda: report - FirstWord Pharma

Halozyme claims the new Keytruda formulation infringes on its Mdase enzyme patents, which broadly cover modified human hyaluronidases for drug ...

30. Promega Files Patent Infringement Lawsuit Against Aobious to Protect Novel Luciferase Substrates

Furimazine is a critical component of NanoLuc® luciferase technology developed by Promega, and the company holds multiple active U.S. patents ...

31. ProAmpac secures U.S. patents for sustainable packaging - Petfood Industry

The new patents cover innovations such as the ProActive Recyclable R-2000 and R-2050 Series for a range of applications including dry and frozen foods ...

32. SK Biopharmaceuticals patents new Mat2A inhibitors - BioWorld

To read more on related topics, click on one of the words below. BioWorld Science Cancer Patents. KEYWORDS colon cancer Mat2A inhibitors SK ...

33. Federal Circuit Refuses to Rehear Case Involving Orange Book Listing of Device Patents

Get the latest on the Federal Circuit's decision to deny Teva's rehearing request on device patents in the FDA's Orange Book.

34. New version of Merck's cancer drug faces possible patent battle: reports - The Hindu

Halozyme Therapeutics claims Merck's new Keytruda version infringes on patents, requiring a licensing agreement, reports WSJ.

35. Avoiding a finding of ambiguity and ensuring patent validity - JD Supra

Both patents pertain to an atomization manufacturing process which claims to improve the flowability of the resulting powder particles. All claims of ...

36. Case: Patents/Obviousness (Fed. Cir.) - Bloomberg Law

Case: Patents/Obviousness (Fed. Cir.) The Federal Circuit affirmed the decision of the Patent Trial and Appeal Board that some challenged claims ...

37. Pfizer, BioNTech Get PTAB To Invalidate Moderna Vaccine IP - Law360

The Patent Trial and Appeal Board handed a massive victory to Pfizer and BioNTech on Wednesday, as it invalidated two Moderna patents covering its ...

38. Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents

Pfizer NYSE:PFE and BioNTech NASDAQ:BNTX won a round in their legal battle with Moderna NASDAQ:MRNA over COVID-19 vaccine patents on Wednesday, ...

39. Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office ...

40. New Version of Merck's Blockbuster Cancer Drug Threatened by Patent Battle - WSJ

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling a new version of its drug Keytruda.

41. Pfizer and BioNTech COVID vaccine broke patent: German court - Medical Xpress

Moderna successfully persuaded the court that patents it had filed over the period 2010 to 2016 were valid and relevant to the case. The ruling ...

42. Moderna mRNA Vaccine-Delivery Patents Invalidated by Tribunal - Bloomberg Law

Pfizer Inc. and BioNTech SE convinced an administrative tribunal to throw out portions of two patents Moderna Inc. asserted against the companies ...

43. Promega Files Patent Infringement Lawsuit Against Aobious to Protect Novel Luciferase Substrates

The lawsuit aims to halt unauthorized sales of furimazine substrates by Aobious. Furimazine substrates are protected by multiple active patents held ...